fludarabine and Cell Transformation, Viral

fludarabine has been researched along with Cell Transformation, Viral in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chamo, M; Gazit, R; Goldstein, O; Ilic, S; Keinan, N; Scharff, Y1
Aractingi, S; Auffret, N; Bodemer, C; Brousse, N; Duong, T; Fraitag, S; Grange, F; Hermine, O1
Fong, D; Gastl, G; Kaiser, A; Spizzo, G; Tzankov, A1
Arcaini, L; Astori, C; Baldanti, F; Bernasconi, C; Furione, M; Gerna, G; Lazzarino, M; Orlandi, E; Pagnucco, G; Paulli, M; Viglio, A1

Reviews

1 review(s) available for fludarabine and Cell Transformation, Viral

ArticleYear
Cutaneous Richter's syndrome, prognosis, and clinical, histological and immunohistological patterns: report of four cases and review of the literature.
    Dermatology (Basel, Switzerland), 2010, Volume: 220, Issue:3

    Topics: Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; CD5 Antigens; Cell Transformation, Viral; Epstein-Barr Virus Infections; Fatal Outcome; Female; Herpesvirus 4, Human; Humans; Ki-1 Antigen; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prognosis; Skin Neoplasms; Vidarabine

2010

Other Studies

3 other study(ies) available for fludarabine and Cell Transformation, Viral

ArticleYear
Syngeneic leukemia models using lentiviral transgenics.
    Cell death & disease, 2021, 02-18, Volume: 12, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Viral; Gene Expression Regulation, Leukemic; Hematopoietic Stem Cells; Immunocompetence; Lentivirus; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Transplantation; Oncogenes; Transplantation, Isogeneic; Vidarabine

2021
Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
    British journal of haematology, 2005, Volume: 129, Issue:2

    Topics: Antineoplastic Agents; Cell Transformation, Viral; Clone Cells; Drug Resistance, Neoplasm; Epstein-Barr Virus Infections; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Hodgkin Disease; Humans; Immunoglobulin Heavy Chains; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Micromanipulation; Middle Aged; Reed-Sternberg Cells; Vidarabine

2005
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders.
    British journal of haematology, 1999, Volume: 107, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Viral; Cyclophosphamide; Dexamethasone; Epstein-Barr Virus Infections; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Opportunistic Infections; Vidarabine; Virus Activation

1999